Fog/Mist 44°
Tag:

Ridgeback Biotherapeutics

News
COVID-19: Drugmaker To Seek Emergency Approval For Pill To Treat Virus COVID-19: Drugmaker To Seek Emergency Approval For Pill To Treat Virus
Covid-19: Drugmaker To Seek Emergency Approval For Pill To Treat Virus A new pharmaceutical company is throwing its hat in the ring as the country continues its fight against COVID-19. Merck and Ridgeback Biotherapeutics announced on Friday, Oct. 1 that it is planning to apply for federal emergency approval of a pill that can reportedly help prevent hospitalizations and deaths in COVID-19 patients. According to the company, trials have found that the pill - dubbed molnupiravir - could potentially reduce the risk of hospitalization or death in patients with mild to moderate COVID-19 by approximately 50 percent. The results of the late-stage trial have bee…

SHARE

by Zak Failla
Lifestyle
COVID-19: Little Brown Pill Could Be Difference Maker In Fight Against Virus COVID-19: Little Brown Pill Could Be Difference Maker In Fight Against Virus
Covid-19: Little Brown Pill Could Be Difference Maker In Fight Against Virus Scientists may have cracked the code to help in the fight against COVID-19 and potential future pandemics. Though still in clinical trials, the “little brown pill” molnupiravir may give doctors and researchers a new tool and treatment as the country continues combating the latest wave of COVID-19 cases. Merck (also known as MSD), and Ridgeback Biotherapeutics, LP announced earlier this month that they ran a randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability, and efficacy of the pill to eliminate the strain that causes COVID-19. According to the prelimin…

SHARE

by Zak Failla